Healthcare Holding B.V. Gilde Sells 3,900 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 3,900 shares of the company’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $22.60, for a total transaction of $88,140.00. Following the completion of the sale, the insider owned 2,208,307 shares of the company’s stock, valued at approximately $49,907,738.20. This represents a 0.18% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.62, for a total value of $15,404.22.
• On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.61, for a total value of $463,866.76.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.64, for a total value of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total value of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.73, for a total transaction of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Stock Up 0.8%

Shares of Shoulder Innovations stock traded up $0.18 on Monday, hitting $22.24. The company had a trading volume of 75,051 shares, compared to its average volume of 128,345. The firm has a market capitalization of $463.02 million and a P/E ratio of -11.58. Shoulder Innovations, Inc. has a twelve month low of $10.92 and a twelve month high of $24.59. The company has a debt-to-equity ratio of 0.12, a current ratio of 10.71 and a quick ratio of 8.92. The stock has a 50-day moving average of $21.03 and a 200-day moving average of $16.60.

Shoulder Innovations (NYSE:SI) last issued its quarterly earnings data on Thursday, August 6th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). The company had revenue of $17.18 million for the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. Research analysts predict that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current year.

Institutional Trading of Shoulder Innovations

Several institutional investors and hedge funds have recently added to or reduced their stakes in SI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Shoulder Innovations in the 3rd quarter valued at about $28,000. Compass Financial Management LLC acquired a new position in Shoulder Innovations during the second quarter worth approximately $30,000. Rhumbline Advisers acquired a new stake in shares of Shoulder Innovations in the third quarter valued at approximately $54,000. California State Teachers Retirement System boosted its stake in shares of Shoulder Innovations by 412.4% during the 2nd quarter. California State Teachers Retirement System now owns 2,941 shares of the company’s stock worth $60,000 after acquiring an additional 2,367 shares during the period. Finally, Wells Fargo & Company MN increased its holdings in shares of Shoulder Innovations by 66.3% during the 4th quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock worth $75,000 after acquiring an additional 2,094 shares during the last quarter.

Analyst Upgrades and Downgrades

SI has been the subject of several recent research reports. UBS Group upped their price objective on Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. BTIG Research boosted their target price on Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Weiss Ratings raised Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 3rd. Finally, Piper Sandler reiterated an “overweight” rating and issued a $25.00 price objective (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. Six research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $23.50.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.